The number of Zofran lawsuits filed in courts around the country continues to increase. Parents claim that Zofran manufacturers GlaxoSmithKline (GSK) failed to provide adequate warnings about the risks of birth defects when the medication is taken by pregnant women. Considering the rising litigation
Federal Xarelto lawsuits were consolidated into the Eastern District of Louisiana in December 2014. Since then, the number of Xarelto lawsuits filed has continued to increase. In the first week of August 2015, nearly 200 cases joined the MDL bundled together as four different lawsuits.…
On July 27, 2015, a North Dakota couple filed a new Zofran lawsuit on behalf of their son, a minor. The case is currently pending in the U.S. District Court for the District of North Dakota. According to their complaint, after the mother took Zofran…
Progress is being made in the testosterone MDL proceedings taking place in the Northern District of Illinois. There are nearly 2,000 testosterone lawsuits pending there, filed by plaintiffs who claim to have taken testosterone replacement drugs and then suffered from serious side effects like heart…
In July 2015, GlaxoSmithKline (GSK) filed a motion to consolidate all federal Zofran lawsuits in the U.S. District Court for the Eastern District of Pennsylvania. They noted that the cases had similar common questions of fact, and that consolidation would help establish consistent standards for…
Patients who have type 2 diabetes strive to keep their blood sugar levels under control for many health reasons, but particularly to protect their blood vessels. Cardiovascular disease is the number-one killer for those with diabetes, so doctors are often very focused on helping patients…
The number of men filing lawsuits against manufacturers of testosterone replacement drugs continues to climb. These manufacturers, the plaintiffs claim, failed to provide adequate warnings about the risks their products presented to men’s health, including a potentially increased risk of heart attac
On July 6, 2015, GlaxoSmithKline (GKS), manufacturers of the anti-nausea drug Zofran, filed a motion requesting consolidation of all federal Zofran lawsuits. They stated that bringing all the cases together into one court would facilitate more efficient pre-trial proceedings, reduce the risk of inco
Last May (2015), the FDA warned healthcare professionals and type 2 diabetes patients that so-called SGLT2 inhibitors, like Invokana, could potentially increase risk of diabetic ketoacidosis, a dangerous condition that can lead to dehydration, coma, and even death. Among those who weren’t surprised:
The FDA approved the anti-coagulant Xarelto (rivaroxaban) to reduce the risk of blood clots in patients going through knee and hip replacement surgery in 2011, and then later to reduce the risk of stroke in patients with non-valvular atrial fibrillation. Within just a year of…
It’s not only women who experience changes as they get older. Men, too, can suffer from reduced libido, muscle loss, increased weight, and dropping energy levels. Though these are typical symptoms of aging, several testosterone-replacement drug manufacturers used marketing materials and advertisemen
Type 2 diabetes patients taking Invokana (canagliflozin) or other similar drugs to lower blood sugar may have an increased risk of yeast infections, as well as recurring infections, according to new research. Invokana has been previously linked to urinary tract infections and kidney problems, and…